Time-Dependent Vascular Effects of Endocannabinoids Mediated by Peroxisome Proliferator-Activated Receptor Gamma (PPAR𝛾)

Figure 2

The effects of the CB₁ receptor antagonist AM251 (1 μM, (a), and (b)) and the CB₂ receptor antagonist AM630 (1 μM, (c), and (d)) on vasorelaxation to anandamide and NADA. Data are given as means with error bars representing SEM. (^∗𝑃<.05, ^∗∗𝑃<.01, Student’s t-test.)

(a)

(b)

(c)

(d)